Chemokine receptors in gastric MALT lymphoma: Loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma

Modern Pathology

Volumn 26, Issue 2, 2013, Pages 182-194

  Deutsch, Alexander J A ^a   Steinbauer, Elisabeth ^a   Hofmann, Nicole A ^a   Strunk, Dirk ^a   Gerlza, Tanja ^a   Beham Schmid, Christine ^a   Schaider, Helmut ^a   Neumeister, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

chemokine receptor; chemokines; CXCR4; CXCR7; MALT lymphoma; transformed MALT lymphoma

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; MESSENGER RNA;

ARTICLE; AUTOCRINE EFFECT; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; GASTRIC EXTRADONAL DIFFUSE LARGE B CELL LYMPHOMA; GASTRIC MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH; STOMACH TUMOR; TISSUE SECTION; TUMOR GROWTH; TUMOR LOCALIZATION;

DISEASE PROGRESSION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR; RECEPTORS, CXCR4; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84873406159     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.134     Document Type: Article

References (61)

1. Isaacson PG. Du M-Q. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004;4:644.
2. Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity. Immunol Rev 2003;195:58-71.
3. Laurence AD. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. Br J Haematol 2006;132:255-267.
4. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-550.
5. Bowman EP, Campbell JJ, Soler D, et al. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med 2000;191: 1303-1318.
6. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005;23:127-159.
7. Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003;195:117-135.
8. Trentin L, Agostini C, Facco M, et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest 1999;104:115-121.
9. Trentin L, Cabrelle A, Facco M, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004; 104:502-508.
10. Ohshima K, Suefuji H, Karube K, et al. Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism. Leuk Lymphoma 2003;44:329-336.
11. Suefuji H, Ohshima K, Karube K, et al. CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone. Int J Cancer 2005;114:896-901.
12. Golay J, Introna M. Chemokines and antagonists in non-Hodgkin's lymphoma. Expert Opin Ther Targets 2008;12:621-635.
13. Jaffe ES, Harris NL, Stein H, et al. World Health Organisation Classification of Tumors, Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001.
14. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990;136:1153.
15. Tsuji S, Hisaoka M, Morimitsu Y, et al. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol 1998;153:1807-1812.
16. Deutsch AJ, Aigelsreiter A, Steinbauer E, et al. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol 2008;215:431-444.
17. Seidl H, Richtig E, Tilz H, et al. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum Pathol 2007;38:768.
18. Infantino S, Moepps B, Thelen M. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol 2006;176:2197-2207.
19. Neote K, DiGregorio D, Mak JY, et al. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72: 415-425.
20. Ehtesham M, Yuan X, Kabos P, et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004;6:287-293.
21. Zhang L, Yeger H, Das B, et al. Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 2007;9:36-46.
22. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006;203:2201-2213.
23. Gillette JM, Larochelle A, Dunbar CE, et al. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nat Cell Biol 2009;11:303-311.
24. Hayakawa J, Migita M, Ueda T, et al. Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells. J Nippon Med Sch 2009;76:198-208.
25. Kyriakou C, Rabin N, Pizzey A, et al. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 2008;93:1457-1465.
26. Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62: 1832-1837.
27. Sun YX, Wang J, Shelburne CE, et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003;89:462-473.
28. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549.
29. Jones D, Benjamin RJ, Shahsafaei A, et al. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 2000;95:627-632.
30. Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999;104:R49-R54.
31. Rodig SJ, Jones D, Shahsafaei A, et al. CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomas. Hum Pathol 2002;33:1227-1233.
32. Rehm A, Anagnostopoulos I, Gerlach K, et al. Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma. Int J Cancer 2009;125:2367-2374.
33. Shen X, Mailey B, Ellenhorn JD, et al. CC chemo-kine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells. J Gastrointest Surg 2009;13:1955-1962.
34. Kunkel EJ, Campbell JJ, Haraldsen G, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000;192:761-768.
35. Kiriya K, Watanabe N, Nishio A, et al. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis. Int Immunol 2007;19:435-446.
36. Wu Y-Y, Tsai H-F, Lin W-C, et al. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect Immun 2007;75:4357-4363.
37. Yoshida A, Isomoto H, Hisatsune J, et al. Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis. Clin Immunol 2009;130:290-297.
38. Galamb O, Gyorffy B, Sipos F, et al. Helicobacter pylori and antrum erosion-specific gene expression patterns: the discriminative role of CXCL13 and VCAM1 transcripts. Helicobacter 2008;13:112-126.
39. Hansson M, Hermansson M, Svensson H, et al. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immuno-globulin a-secreting cells. Infect Immun 2008;76: 3304-3311.
40. Hansson M, Lundgren A, Elgbratt K, et al. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3[beta]) after exposure to Helicobacter pylori. Microb Infect 2006;8:841-850.
41. Schmausser B, Endrich S, Brandlein S, et al. The chemokine receptor CCR7 is expressed on epithelium of non-inflamed gastric mucosa, Helicobacter pylori gastritis, gastric carcinoma and its precursor lesions and up-regulated by H. pylori. Clin Exp Immunol 2005;139:323-327.
42. Smith MC, Luker KE, Garbow JR, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004;64:8604-8612.
43. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
44. Kollmar O, Rupertus K, Scheuer C, et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007;9: 862-870.
45. Engl T, Relja B, Marian D, et al. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006;8: 290-301.
46. Sung B, Jhurani S, Ahn KS, et al. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res 2008; 68:8938-8944.
47. Marlow R, Strickland P, Lee JS, et al. SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res 2008;68:7819-7827.
48. Schabath H, Runz S, Joumaa S, et al. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 2006;119:314-325.
49. Holland JD, Kochetkova M, Akekawatchai C, et al. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res 2006;66:4117-4124.
50. Miao Z, Luker KE, Summers BC, et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007;104:15735-15740.
51. Sierro F, Biben C, Martinez-Munoz L, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 2007;104: 14759-14764.
52. Zhang P, Li W, Wang Y, et al. Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis. Mol Immunol 2007;44:332-337.
53. Wang J, Shiozawa Y, Wang Y, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008;283:4283-4294.
54. Mazzinghi B, Ronconi E, Lazzeri E, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008;205:479-490.
55. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004;14:171-179.
56. Wang H, Beaty N, Chen S, et al. The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 2011;119:465-468.
57. Beider K, Ribakovsky E, Abraham M, et al. CXCR4 antagonist BKT140 synergizes with rituximab, targeting non Hodgkin lymphoma (NHL) in vitro and in vivo in a xenograft model with bone marrow involvement. ASH Annu Meet Abstr 2011;118:952.
58. Gutierrez-Garcia G, Colomo L, Villamor N, et al. Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2010;51:1225-1232.
59. Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005;23: 2797-2804.
60. Viswanatha D, Foucar K. Hodgkin and non-Hodgkin lymphoma involving bone marrow. Semin Diagn Pathol 2003;20:196-210.
61. Khurram SA, Whawell SA, Bingle L, et al. Functional expression of the chemokine receptor XCR1 on oral epithelial cells. J Pathol 2010;221:153-163.